PLOD2 and nonpapillary renal cell carcinoma: Furthermore, PLOD2 knockout significantly abrogated hypoxia-induced β-catenin expression at both the mRNA (Fig. 4F) and protein levels (Fig. 4G) in both ccRCC cell lines.